Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Cassiopea S P A manages a patent portfolio in the Biotechnology & Pharmaceuticals technology area. The current prosecution activity involves 1 pending office action. This matter is assigned to 1 distinct examiner, PEEBLES, KATHERINE, within a single distinct art unit.
As the busiest examiner, PEEBLES, KATHERINE is responsible for the busiest examiner pending action in the records. This concentration of responsibility means the applicant interacts with a single point of contact at the patent office. The Biotechnology & Pharmaceuticals focus is maintained through this specific administrative channel. Practitioners can focus their strategy on the requirements of the only examiner involved to move the pending matter forward.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| PEEBLES, KATHERINE | 1 | 35.6% | +48.0% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18539531 | HIGH CONCENTRATION FORMULATION | PEEBLES, KATHERINE | — |
| Art Unit | Apps |
|---|---|
| 1617 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18539531 | HIGH CONCENTRATION FORMULATION | PEEBLES, KATHERINE | 1617 | §103§112DP | Final Rejection | — | Pending | Dec 14, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialCassiopea S P A has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Katherine Peebles has the most, with 1 of Cassiopea S P A's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
